AKT1 and acute myeloid leukemia: This study aims to investigate the impact of PI3K/AKT/mTOR pathway inhibition on autophagy in AML cell lines, to identify potential therapeutic interventions that can enhance the treatment of AML through targeted modulation of autophagy.